FDA declines to approve Pain Therapeutics' abuse-deterrent opioid drug

Pain Therapeutics said on Monday that the U.S. Food and Drug Administration declined to approve its opioid drug for the management of severe pain as the benefits of the drug did not outweigh the risk.